Studies on Hydrogel-Based Diclofenac Epolamine Topical Patch in Comparison with Flector® Patch

被引:0
|
作者
Kamal, Mehnaz [1 ]
Sinha, Mukty [2 ]
Jawaid, Talha [3 ]
Alfadhel, Munerah [4 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, POB 173, Al Kharj 11942, Saudi Arabia
[2] NIPER Ahmedabad, Dept Med Devices, Palej Basan Rd, Gandhinagar 382355, Gujarat, India
[3] Al Imam Mohammad Ibn Saud Islamic Univ IMSIU, Coll Med, Dept Pharmacol, Riyadh 13317, Saudi Arabia
[4] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut, POB 173, Al Kharj 11942, Saudi Arabia
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2022年 / 41卷 / 03期
关键词
diclofenac epolamine; Flector (R); sodium carboxymethyl cellulose; NSAIDs; topical drug delivery; IN-VITRO; PENETRATION; PERMEATION; KETOPROFEN; DELIVERY; ESTERS; ACID; RAT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diclofenac sodium is a well-known nonsteroidal anti-inflammatory drug (NSAIDs) that is commonly used to treat musculoskeletal problems, toothaches, arthritis, and dysmenorrhoea, as well as to provide symptomatic pain and inflammation relief. However, oral administration of these therapeutic drugs has a number of side effects that can be avoided by using a topical drug delivery system. Diclofenac epolamine is a newer salt with a cyclic salt form that has better skin permeability and fewer adverse effects. In the present study, diclofenac epolamine (180 mg) in adhesive type topical patch, were prepared using three different grades of sodium carboxymethyl cellulose viz., LF, M1F and MF. Mixtures of transdermal enhancers like propylene glycol and butylene glycol, humectants and other excipient were included as part of the vehicle. Cumulative permeation and flux studies were carried out through Strat-M (R) membrane using Hanson and Franz diffusion cell, respectively. Adhesion study was carried out to see its effectiveness towards longer adhesion time onto the skin. The results were compared with marketed product, Flector (R). It was found that the M1F grade was best for the topical patch ibrmulation and as much effective as the marketed product in terms of its drug delivery and skin adhesion properties.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 50 条
  • [1] Diclofenac Epolamine (Flector®) Patch Evidence for Topical Activity
    Petersen, Birte
    Rovati, Stefano
    CLINICAL DRUG INVESTIGATION, 2009, 29 (01) : 1 - 9
  • [2] DICLOFENAC EPOLAMINE TOPICAL PATCH FOR THE TREATMENT OF PAIN
    Affaitati, G.
    Giamberardino, M. A.
    Lapenna, D.
    Costantini, R.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (03): : 435 - 441
  • [3] Diclofenac Epolamine (Flector®) PatchEvidence for Topical Activity
    Birte Petersen
    Stefano Rovati
    Clinical Drug Investigation, 2009, 29 : 1 - 9
  • [4] A diclofenac patch (Flector) for pain
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1277): : 1 - 2
  • [5] Diclofenac Epolamine Patch (Flector®) Versus Oral Naproxen For Pain Relief Of Minor Sports Injuries
    Borchers, James
    Pedroza, Angela
    Novak, Jennifer
    Beisner, Angie
    Flanigan, David
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (05): : 202 - 203
  • [6] A comparative cost-effectiveness analysis on the use of flector(r) patch (diclofenac epolamine topical patch) 1.3% versus Lidoderm® (lidocaine patch 5%) for the treatment of acute pain following injury
    Carter, C. A.
    Dunsworth, G. A.
    Brookfield, R. B.
    VALUE IN HEALTH, 2008, 11 (03) : A157 - A157
  • [7] Gastrointestinal Tolerability of Diclofenac Epolamine Topical Patch 1.3%: A Pooled Analysis of 14 Clinical Studies
    Brewer, Alan R.
    Pierchala, Lisa A.
    Yanchick, Jillmarie K.
    Magelli, Merrell
    Rovati, Stefano
    POSTGRADUATE MEDICINE, 2011, 123 (04) : 168 - 176
  • [8] Time to Resolution of Pain from Minor Soft Tissue Injury With Diclofenac Epolamine Topical Patch
    Kuehl, K.
    Yanchick, J.
    Magelli, M.
    Rovati, S.
    Fuller, C.
    Blackburn, K.
    ANNALS OF EMERGENCY MEDICINE, 2008, 52 (04) : S74 - S74
  • [9] Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury
    McCarberg, B. H.
    Argoff, C. E.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (11) : 1546 - 1553
  • [10] Efficacy and Tolerability of Diclofenac Epolamine Topical Patch for Treatment of Minor Soft-Tissue Injury Pain
    Sun, Stephen
    Carr, William
    Beks, Pieter
    Jones, Clarence
    Rovati, Stefano
    Magelli, Merrell
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2008, 40 (05): : S6 - S6